Sleepiz AG, a Swiss medical technology start-up, has announced that it has received USD 500K funding to enable the future of sleep diagnostics through a novel three-dimensional radar technology.
Funded by the European Union’s Horizon 2020 Eurostars grant, Sleepiz AG is collaborating with Acconeer, a Swedish radar sensor company, and working in partnership with the University of Gothenburg’s Sleep Medicine Centre. A total of USD 1M has been granted for the research between Sleepiz and Acconeer.
Sleepiz, who were winners of the EIT Health Headstart programme and the regional EIT Health Catapult in Germany, has recently entered the market with its first medical device, the Sleepiz One. The device, designed to help people who suffer from sleep apnea manage their condition, operates in a non-contact fashion and measures movements originating from heart contractions and breathing patterns, as well as body motions with medical-grade accuracy.
By combining expertise in both medical and radar industries, the collaboration will develop the next generation of contactless devices. The radar aims to enable better personalised therapy through a novel three-dimensional monitoring approach, providing more insights and standards than the current state of the art devices. The project is due to begin in May 2021 and will be carried out for three years.
For Sleepiz, such recognition and trust by the European Union allow us to envision the future of healthcare that is deeply rooted in the power of medicine and technology combined. Our goal for this collaboration with Acconeer and the University of Gothenburg is to continuously progress the status quo and create the next generation of our sleep monitoring device that will improve people’s lives with the most innovative technology available. All at the comfort of one’s home.
Soumya Dash, the CEO and co-founder of Sleepiz AG